These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8896878)

  • 1. Further studies on the efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs.
    Scott DW; Miller WH; Rothstein SE; Bagladi MS
    Can Vet J; 1996 Oct; 37(10):617-8. PubMed ID: 8896878
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs.
    Scott DW; Miller WH; Cayatte SM; Bagladi MS
    Can Vet J; 1994 Oct; 35(10):617-21. PubMed ID: 7994702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma, the march of the staphylococci.
    Loeffler A; Lloyd DH
    Vet Dermatol; 2014 Aug; 25(4):285-6. PubMed ID: 25124174
    [No Abstract]   [Full Text] [Related]  

  • 4. Canine superficial pyoderma and therapeutic considerations.
    Bajwa J
    Can Vet J; 2016 Feb; 57(2):204-6. PubMed ID: 26834275
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.
    Scott DW; Beningo KE; Miller WH; Rothstein E
    Can Vet J; 1998 Dec; 39(12):753-6. PubMed ID: 9861499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical therapy for drug-resistant pyoderma in small animals.
    Jeffers JG
    Vet Clin North Am Small Anim Pract; 2013 Jan; 43(1):41-50. PubMed ID: 23182323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tylosin in the treatment of canine superficial pyoderma.
    Harvey RG
    Vet Rec; 1996 Aug; 139(8):185-7. PubMed ID: 8873399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs: effect of pyoderma, pruritus score, treatment and gender.
    Simou C; Thoday KL; Forsythe PJ; Hill PB
    Vet Dermatol; 2005 Dec; 16(6):385-91. PubMed ID: 16359305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma.
    Ganiere JP; Medaille C; Mangion C
    J Vet Med B Infect Dis Vet Public Health; 2005 Feb; 52(1):25-31. PubMed ID: 15702997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of production of Staphylococcus intermedius exotoxin among clinically normal dogs, atopic dogs with recurrent pyoderma, and dogs with a single episode of pyoderma.
    Burkett G; Frank LA
    J Am Vet Med Assoc; 1998 Jul; 213(2):232-4. PubMed ID: 9676593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of cefadroxil and generic and proprietary cephalexin in the treatment of pyoderma in dogs.
    Frank LA; Kunkle GA
    J Am Vet Med Assoc; 1993 Aug; 203(4):530-3. PubMed ID: 8407508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tylosin tartrate on canine Staphylococcus intermedius isolates in vitro.
    Scott BA; Mortensen JE; McKeever TM; Logas DB; McKeever PJ
    Vet Ther; 2010; 11(3):E1-7. PubMed ID: 20960412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An English bulldog with MRSP].
    Sinke J
    Tijdschr Diergeneeskd; 2013 Sep; 138(9):50. PubMed ID: 24133778
    [No Abstract]   [Full Text] [Related]  

  • 14. Lincosamide resistance is less frequent in Denmark in Staphylococcus pseudintermedius from first-time canine superficial pyoderma compared with skin isolates from clinical samples with unknown clinical background.
    Larsen R; Boysen L; Berg J; Guardabassi L; Damborg P
    Vet Dermatol; 2015 Jun; 26(3):202-5, e43-4. PubMed ID: 25891140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clindamycin for first-time or recurrent canine staphylococcal pyoderma.
    Scott DW; Miller WH
    Vet Dermatol; 2016 Feb; 27(1):62-3. PubMed ID: 26597349
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma.
    Hartmann FA; White DG; West SE; Walker RD; Deboer DJ
    Vet Microbiol; 2005 Jun; 108(1-2):119-31. PubMed ID: 15917140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs.
    Scott DW; Peters J; Miller WH
    Can Vet J; 2006 Oct; 47(10):999-1002. PubMed ID: 17078249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of aerobic bacteriologic culture of epidermal collarette specimens in dogs with superficial pyoderma.
    White SD; Brown AE; Chapman PL; Jang SS; Ihrke PJ
    J Am Vet Med Assoc; 2005 Mar; 226(6):904-8. PubMed ID: 15786991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior antibacterial drug exposure in dogs with meticillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma.
    Hensel N; Zabel S; Hensel P
    Vet Dermatol; 2016 Apr; 27(2):72-8e20. PubMed ID: 26909526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant interferonalpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study.
    Thompson LA; Grieshaber TL; Glickman L; Glickman N
    Vet Ther; 2004; 5(1):75-81. PubMed ID: 15150732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.